|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Seres Therapeutics, Inc.
| | | Phone: | (617) 945-9626 | Year Established: | 2010 | Ticker: | MCRB | Exchange: | NASDAQ | Main Contact: | Henry Rath, VP, Business Development | | Other Contacts: | Thomas J. DesRosier, CLO Matthew Henn, Ph.D., Senior VP, Head of Drug Discovery & Bioinformatics Kevin Horgan, M.D., Executive VP & CMO Eric Shaff, Executive VP & CCO David Cook, Ph.D., Executive VP R&D & CSO John Aunins Ph.D., Executive VP, Bioprocess & Manufacturing & CTO Roger Pomerantz, M.D., President, CEO & Chairman
| | Company Description | Seres Therapeutics is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome. | |
|
|
|
|
|